Home › Companies › ELEVANCE HEALTH INC. › 2023-2024

ELEVANCE HEALTH INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and ELEVANCE HEALTH INC.’s Form 8-K, filed May 15, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

6Ballot items
1,184Asset managers
8,509Fund votes
May 15, 2024Meeting date

Results at a glance

Meeting of May 15, 2024: 6 items on ELEVANCE HEALTH INC.’s Form 8-K, filed May 15, 2024: 3 elected · 2 approved · 1 not approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ELEVANCE HEALTH INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by ELEVANCE HEALTH INC.

These tallies are ELEVANCE HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 15, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ELEVANCE HEALTH INC. — official shareholder meeting results, meeting held May 15, 2024
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Lewis Hay, III	191,694,052	4,384,617	196,126	--	12,814,049	98%	Elected	—
Elect Director: Antonio F. Neri	189,550,610	6,514,535	209,650	--	12,814,049	97%	Elected	—
Elect Director: Ramiro G. Peru	183,447,281	12,625,588	201,926	--	12,814,049	94%	Elected	—
2. Advisory vote on the Company's executive compensation	179,754,212	15,863,613	656,970	--	12,814,049	92%	Approved	—
3. Ratification of the appointment of Ernst & Young LLP	186,378,524	22,541,679	168,641	--	--	89%	Approved	—
4. Shareholder proposal requesting annual political activity reporting from certain third parties prior to the Company donating to the organizations	9,977,190	184,179,837	2,117,768	--	12,814,049	5%	Not approved	—

Source: ELEVANCE HEALTH INC., Form 8-K, filed with the SEC on May 15, 2024 — read the filing on EDGAR.

How asset managers voted at the ELEVANCE HEALTH INC. 2023-2024 meeting

Each item below shows how the 1,184 asset managers that disclosed a ELEVANCE HEALTH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Lewis Hay, III

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 191,694,052AGAINST: 4,384,617

Details: description as filed, official tally, votes by 207 asset managers

Description as filed by funds: Election of Directors: Lewis Hay, III

ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Lewis Hay, III”): 191,694,052 for, 4,384,617 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2027 based on the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 207 asset managers below reported 74,804,910 for, 91,503 against, 44,757 abstained, 759 not voted.

FOR

FOR: 74,804,910AGAINST: 91,503ABSTAIN: 44,757NOT VOTED: 759

Largest asset managers voting on “Election of Directors: Lewis Hay, III” at ELEVANCE HEALTH INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Vanguard	20,653,011	0	0	For
Fidelity	7,273,103	0	0	For
BlackRock	6,976,980	0	0	For
T. Rowe Price	5,952,271	7,747	0	For
Capital Group	2,801,711	0	0	For
State Street	2,357,710	0	0	For
Columbia Threadneedle	2,281,594	0	0	For
TIAA	2,120,207	0	0	For
Dimensional	1,564,809	0	0	For
Invesco	1,561,023	0	0	For
Charles Schwab	1,538,257	0	0	For
FIRST EAGLE FUNDS	1,338,686	0	0	For
MFS	1,151,616	0	0	For
JPMorgan	1,031,096	0	0	For
First Trust	880,748	0	0	For
FRANKLIN MUTUAL SERIES FUNDS	849,551	0	0	For
Brighthouse	740,860	0	43,903	Mixed
John Hancock	776,982	0	0	For
Hartford	753,212	0	0	For
Jackson National	596,720	0	0	For
GMO	532,654	0	0	For
Prudential/PGIM	431,033	0	0	For
Voya	418,622	0	0	For
Nuveen	414,168	0	0	For
MASTER INVESTMENT PORTFOLIO	368,974	0	0	For

Showing the 25 largest of 207 asset managers. See all 207 in the interactive database.

2. Elect Director: Antonio F. Neri

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 189,550,610AGAINST: 6,514,535

Details: description as filed, official tally, votes by 207 asset managers

Description as filed by funds: Election of Directors: Antonio F. Neri

ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Antonio F. Neri”): 189,550,610 for, 6,514,535 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2027 based on the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 207 asset managers below reported 72,703,404 for, 2,188,515 against, 49,252 abstained, 759 not voted.

FOR

FOR: 72,703,404AGAINST: 2,188,515ABSTAIN: 49,252NOT VOTED: 759

Largest asset managers voting on “Election of Directors: Antonio F. Neri” at ELEVANCE HEALTH INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Vanguard	20,653,011	0	0	For
Fidelity	7,273,103	0	0	For
BlackRock	6,976,980	0	0	For
T. Rowe Price	5,952,271	7,747	0	For
Capital Group	2,801,711	0	0	For
State Street	2,357,710	0	0	For
Columbia Threadneedle	2,281,594	0	0	For
TIAA	2,120,207	0	0	For
Dimensional	1,564,809	0	0	For
Invesco	0	1,561,023	0	Against
Charles Schwab	1,538,257	0	0	For
FIRST EAGLE FUNDS	1,338,686	0	0	For
MFS	1,151,616	0	0	For
JPMorgan	1,031,096	0	0	For
First Trust	880,748	0	0	For
FRANKLIN MUTUAL SERIES FUNDS	849,551	0	0	For
Brighthouse	268,518	472,342	43,903	Mixed
John Hancock	771,640	5,342	0	For
Hartford	753,099	113	0	For
Jackson National	596,720	0	0	For
GMO	532,654	0	0	For
Prudential/PGIM	431,033	0	0	For
Voya	418,622	0	0	For
Nuveen	414,168	0	0	For
MASTER INVESTMENT PORTFOLIO	368,974	0	0	For

Showing the 25 largest of 207 asset managers. See all 207 in the interactive database.

3. Elect Director: Ramiro G. Peru

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 183,447,281AGAINST: 12,625,588

Details: description as filed, official tally, votes by 207 asset managers

Description as filed by funds: Election of Directors: Ramiro G. Peru

ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Ramiro G. Peru”): 183,447,281 for, 12,625,588 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2027 based on the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 207 asset managers below reported 74,487,023 for, 409,390 against, 44,758 abstained, 759 not voted.

FOR

FOR: 74,487,023AGAINST: 409,390ABSTAIN: 44,758NOT VOTED: 759

Largest asset managers voting on “Election of Directors: Ramiro G. Peru” at ELEVANCE HEALTH INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Vanguard	20,653,011	0	0	For
Fidelity	7,273,103	0	0	For
BlackRock	6,976,980	0	0	For
T. Rowe Price	5,952,271	7,747	0	For
Capital Group	2,801,711	0	0	For
State Street	2,357,660	50	0	For
Columbia Threadneedle	2,281,594	0	0	For
TIAA	2,120,207	0	0	For
Dimensional	1,564,809	0	0	For
Invesco	1,561,023	0	0	For
Charles Schwab	1,538,257	0	0	For
FIRST EAGLE FUNDS	1,338,686	0	0	For
MFS	1,151,616	0	0	For
JPMorgan	1,031,096	0	0	For
First Trust	880,748	0	0	For
FRANKLIN MUTUAL SERIES FUNDS	849,551	0	0	For
Brighthouse	740,860	0	43,903	Mixed
John Hancock	776,982	0	0	For
Hartford	753,212	0	0	For
Jackson National	596,720	0	0	For
GMO	532,654	0	0	For
Prudential/PGIM	431,033	0	0	For
Voya	418,622	0	0	For
Nuveen	414,168	0	0	For
MASTER INVESTMENT PORTFOLIO	368,974	0	0	For

Showing the 25 largest of 207 asset managers. See all 207 in the interactive database.

4. 2. Advisory vote on the Company's executive compensation

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 35 wordings of this item as funds reported it.

92% Approved · of votes cast

FOR 92%

FOR: 179,754,212AGAINST: 15,863,613

Details: description as filed, official tally, votes by 1,161 asset managers

Description as filed by funds: Advisory vote to approve the compensation of our named executive officers.

ELEVANCE HEALTH INC.’s own tally for this item (“2. Advisory vote on the Company's executive compensation”): 179,754,212 for, 15,863,613 against — passed, per its Form 8-K filed May 15, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The advisory vote on the compensation of the Company's named executive officers was approved based upon the following votes:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of ELEVANCE HEALTH INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Section 14a Executive Compensation” (15 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 204 asset managers voting on “Advisory vote to approve the compensation of our named executive officers.” at ELEVANCE HEALTH INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Vanguard	20,653,011	0	0	For
Fidelity	7,273,103	0	0	For
BlackRock	6,976,980	0	0	For
T. Rowe Price	5,952,271	7,747	0	For
Capital Group	2,801,711	0	0	For
Artisan	2,431,781	0	0	For
State Street	2,357,660	50	0	For
Columbia Threadneedle	2,281,594	0	0	For
TIAA	2,120,207	0	0	For
Dimensional	1,564,809	0	0	For
Invesco	1,561,023	0	0	For
Charles Schwab	1,538,257	0	0	For
FIRST EAGLE FUNDS	1,338,686	0	0	For
MFS	1,151,616	0	0	For
JPMorgan	1,031,096	0	0	For
First Trust	880,748	0	0	For
FRANKLIN MUTUAL SERIES FUNDS	849,551	0	0	For
Brighthouse	740,860	0	43,903	Mixed
John Hancock	771,640	5,342	0	For
Hartford	753,212	0	0	For
Jackson National	596,720	0	0	For
GMO	532,654	0	0	For
Prudential/PGIM	431,033	0	0	For
Voya	418,622	0	0	For
Nuveen	414,168	0	0	For

Fund voting reports, all 204 managers: 76,769,545 for, 419,589 against, 47,786 abstained, 759 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 990 asset managers voting on “Advisory vote to approve the compensation of our named executive officers.” at ELEVANCE HEALTH INC., 2023-2024
Asset manager	For	Against	Vote
T. Rowe Price	11,581,428	22,006	For
BlackRock	9,478,238	1,774	For
State Street	6,398,691	83,828	For
New York Life	5,000,000	0	For
GEODE CAPITAL MANAGEMENT, LLC	4,659,264	0	For
Wellington	4,331,273	0	For
Fidelity	3,829,926	0	For
Capital Group	3,569,177	100	For
Nuveen	2,842,185	1,150	For
AllianceBernstein	2,526,332	0	For
Sanders Capital, LLC	2,515,637	0	For
Man Group plc	2,382,800	0	For
Northern Trust	2,184,615	21,034	For
National Pension Service	1,901,531	0	For
Brave Warrior Advisors, LLC	1,760,180	0	For
Invesco	1,729,289	0	For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	1,666,575	0	For
First Eagle Investment Management, LLC	1,615,492	0	For
John Hancock	1,597,973	0	For
SCHRODER INVESTMENT MANAGEMENT GROUP	1,583,760	0	For
Charles Schwab	1,553,620	0	For
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC	1,406,317	620	For
Legal & General Investment Management Ltd	0	1,352,177	Against
NORDEA INVESTMENT MANAGEMENT AB	0	1,333,699	Against
MCDONALD CAPITAL INVESTORS INC/CA	1,309,588	0	For

Institutional-manager reports, all 990 managers: 123,019,452 for, 11,458,059 against, 386,688 abstained, 24,326 not voted, 18,352 unknown. Showing the 25 largest; see all in the interactive database.

5. 3. Ratification of the appointment of Ernst & Young LLP

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

89% Approved · of votes cast

FOR 89%

FOR: 186,378,524AGAINST: 22,541,679

Details: description as filed, official tally, votes by 208 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2024.

ELEVANCE HEALTH INC.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP”): 186,378,524 for, 22,541,679 against — passed, per its Form 8-K filed May 15, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024 was ratified based upon the following votes:”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of ELEVANCE HEALTH INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (4 managers, 6,405 for).

The 208 asset managers below reported 72,830,765 for, 2,113,084 against, 44,755 abstained, 759 not voted.

FOR

FOR: 72,830,765AGAINST: 2,113,084ABSTAIN: 44,755NOT VOTED: 759

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2024.” at ELEVANCE HEALTH INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Vanguard	19,515,117	1,137,894	0	Mixed
Fidelity	7,273,103	0	0	For
BlackRock	6,976,980	0	0	For
T. Rowe Price	5,960,018	0	0	For
Capital Group	2,801,711	0	0	For
State Street	2,357,660	50	0	For
Columbia Threadneedle	2,281,594	0	0	For
TIAA	2,120,207	0	0	For
Dimensional	1,564,809	0	0	For
Invesco	1,561,023	0	0	For
Charles Schwab	1,538,257	0	0	For
FIRST EAGLE FUNDS	1,338,686	0	0	For
MFS	1,151,616	0	0	For
JPMorgan	1,031,096	0	0	For
First Trust	880,748	0	0	For
FRANKLIN MUTUAL SERIES FUNDS	849,551	0	0	For
Brighthouse	739,550	1,310	43,903	Mixed
John Hancock	776,982	0	0	For
Hartford	753,099	113	0	For
Jackson National	596,720	0	0	For
GMO	532,654	0	0	For
Prudential/PGIM	431,033	0	0	For
Voya	418,622	0	0	For
Nuveen	414,168	0	0	For
MASTER INVESTMENT PORTFOLIO	368,974	0	0	For

Showing the 25 largest of 208 asset managers. See all 208 in the interactive database.

6. 4. Shareholder proposal requesting annual political activity reporting from certain third parties prior to the Company…

Official resultOTHER SOCIAL ISSUESReported outcome: Not approved

Combines 6 wordings of this item as funds reported it.

5% Not approved · of votes cast

AGAINST

FOR: 9,977,190AGAINST: 184,179,837

Details: description as filed, official tally, votes by 203 asset managers

Description as filed by funds: Shareholder proposal to adopt a policy to require certain third-party organizations to annually report political activity expenditures prior to Elevance Health donating to the organizations.

ELEVANCE HEALTH INC.’s own tally for this item (“4. Shareholder proposal requesting annual political activity reporting from certain third parties prior to the Company donating to the organizations”): 9,977,190 for, 184,179,837 against — failed, per its Form 8-K filed May 15, 2024 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “The shareholder proposal requesting annual political activity reporting from third parties prior to the Company donating to the organization was not approved based upon the following votes:”
Support: 5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 203 asset managers below reported 121,323 for, 67,172,903 against, 282,916 abstained, 759 not voted.

AGAINST

FOR: 121,323AGAINST: 67,172,903ABSTAIN: 282,916NOT VOTED: 759

Largest asset managers voting on “Shareholder proposal to adopt a policy to require certain third-party organizations to annually report politic” at ELEVANCE HEALTH INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Vanguard	0	20,653,011	0	Against
Fidelity	0	7,273,103	0	Against
T. Rowe Price	0	5,960,018	0	Against
Capital Group	0	2,801,711	0	Against
State Street	0	2,357,710	0	Against
Columbia Threadneedle	0	2,281,594	0	Against
TIAA	0	2,120,207	0	Against
Dimensional	0	1,564,809	0	Against
Invesco	0	1,561,023	0	Against
Charles Schwab	0	1,538,257	0	Against
FIRST EAGLE FUNDS	0	1,338,686	0	Against
MFS	0	1,151,616	0	Against
JPMorgan	0	1,031,096	0	Against
First Trust	0	880,748	0	Against
FRANKLIN MUTUAL SERIES FUNDS	0	849,551	0	Against
Brighthouse	0	726,264	54,849	Mixed
John Hancock	5,342	771,640	0	Against
Hartford	0	753,212	0	Against
Jackson National	0	596,720	0	Against
GMO	0	532,654	0	Against
Prudential/PGIM	0	431,033	0	Against
Voya	0	418,622	0	Against
Nuveen	0	414,168	0	Against
AllianceBernstein	0	367,371	0	Against
INVESTMENT CO OF AMERICA	0	365,876	0	Against

Showing the 25 largest of 203 asset managers. See all 203 in the interactive database.

Not shown here: this season’s fund filings also report 1 item from the meeting of May 14, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest ELEVANCE HEALTH INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 232,544,717 shares outstanding at the time of that meeting.

Fund voting reports: top ELEVANCE HEALTH INC. shareholders by shares voted on “Advisory vote to approve the compensation of our named executive officers.”, 2023-2024
#	Asset manager	% of shares outstanding
1	Vanguard	8.88%
2	Fidelity	3.13%
3	BlackRock	3.00%
4	T. Rowe Price	2.56%
5	Capital Group	1.20%
6	Artisan	1.05%
7	State Street	1.01%
8	Columbia Threadneedle	0.98%
9	TIAA	0.91%
10	Dimensional	0.67%

Institutional-manager reports: top ELEVANCE HEALTH INC. shareholders by shares voted on “Advisory vote to approve the compensation of our named executive officers.”, 2023-2024
#	Asset manager	% of shares outstanding
1	T. Rowe Price	4.99%
2	BlackRock	4.08%
3	State Street	2.79%
4	New York Life	2.15%
5	GEODE CAPITAL MANAGEMENT, LLC	2.00%
6	Wellington	1.86%
7	Fidelity	1.65%
8	Capital Group	1.53%
9	Nuveen	1.22%
10	AllianceBernstein	1.09%

Reported ELEVANCE HEALTH INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

ELEVANCE HEALTH INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
Vanguard Group	9.89%	13F
BlackRock	8.83%	13F
T. Rowe Price	5.04%	13F
State Street	4.51%	13F
Geode Capital	2.02%	13F
Wellington Management	1.93%	13F
Capital International	1.50%	13F
Nuveen	1.16%	13F
Morgan Stanley	1.15%	13F
Norges Bank	1.07%	13F

Percentages above are of 232,544,717 shares outstanding, as reported by ELEVANCE HEALTH INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ELEVANCE HEALTH INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At ELEVANCE HEALTH INC.'s shareholder meeting held May 15, 2024, in the 2023-2024 proxy season, 1,184 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 8,509 separate fund positions. On the most widely held item on that ballot — Advisory vote to approve the compensation of our named executive officers. — ELEVANCE HEALTH INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ELEVANCE HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 15, 2024.

ELEVANCE HEALTH INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.